U.S. nearing deal to fund bird flu vaccine trial

The U.S. government is on the verge of finalizing a deal to fund a late-stage trial of Moderna's mRNA-based bird flu vaccine, aiming to enhance its pandemic vaccine reserves as the H5N1 outbreak continues to impact egg farms and cattle herds. Sources familiar with the...